tirzepatide semaglutide head to head A 72-week trial compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide: 13.7% weight loss But weight loss isn't the Tirzepatide versus Semaglutide Once Weekly
Description
#MASH #LiverHealth #GLP1 #Semaglutide #MedicalResearch #CellMetabolism #Hepatology #Innovation | 31 comments on LinkedIn
No direct interaction but alcohol and oral semaglutide don't mix as smoothly as you'd think
Understanding your genetic predispositions and biomarkers can help inform this conversation
GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart disease, Parkinsons, sleep apnea and addiction.
Trace Curry at at JourneyLite discusses gastric sleeve cost, how gastric sleeve works, VSG insurance and their $10k self-pay option.
